Alexander Seelenberger Farba
Director of Finance/CFO at VINCERX PHARMA, INC.
Net worth: 6 536 $ as of 2024-04-29
Profile
Alexander Seelenberger Farba is currently the Chief Financial Officer at Vincerx Pharma, Inc. He also holds director positions at Trigemina, Inc., EchoPixel, Inc., Andes Biotechnologies SA, Algenis SpA, and Levita Magnetics International Corp.
In addition, he is a professor at the University of Chile.
Previously, he was a managing partner at Aurus Capital SA Administradora General de Fondos and held various director positions at PLx Pharma, Inc., Athelera LLC, and The Boston Consulting Group, Inc. He received his undergraduate degree from the University of Chile in 2001 and his MBA from Harvard Business School in 2007.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VINCERX PHARMA INC
0.03% | 2024-03-06 | 7,287 ( 0.03% ) | 6 536 $ | 2024-04-29 |
Alexander Seelenberger Farba active positions
| Companies | Position | Start |
|---|---|---|
| VINCERX PHARMA, INC. | Director of Finance/CFO | 2020-11-30 |
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Director/Board Member | 2009-08-31 |
| University of Chile | Corporate Officer/Principal | - |
EchoPixel, Inc.
 EchoPixel, Inc. Electronic Equipment/InstrumentsElectronic Technology EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA. | Director/Board Member | 2012-08-31 |
Aurus Capital SA Administradora General de Fondos
 Aurus Capital SA Administradora General de Fondos Investment ManagersFinance Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients. | Portfolio Manager-Equities | 2007-12-31 |
Algenis SpA
 Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | Director/Board Member | 2012-11-30 |
Levita Magnetics International Corp.
 Levita Magnetics International Corp. Medical SpecialtiesHealth Technology Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA. | Director/Board Member | 2011-12-31 |
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Director/Board Member | 2012-02-29 |
Aurus Capital SA Administradora General de Fondos (Venture Ca
 Aurus Capital SA Administradora General de Fondos (Venture Ca Investment ManagersFinance Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile. | Private Equity Investor | 2009-02-28 |
Former positions of Alexander Seelenberger Farba
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Alexander Seelenberger Farba
| University of Chile | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VINCERX PHARMA, INC. | Health Technology |
| Private companies | 10 |
|---|---|
PLx Pharma, Inc. /Old/
 PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX. | Health Technology |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Health Technology |
Athelera LLC
 Athelera LLC Investment ManagersFinance Athelera LLC provides financial advisory services. The private company is based in New York, NY. The CEO of the company is Rodrigo Bitar. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
EchoPixel, Inc.
EchoPixel, Inc. Electronic Equipment/InstrumentsElectronic Technology EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA. | Electronic Technology |
Aurus Capital SA Administradora General de Fondos
Aurus Capital SA Administradora General de Fondos Investment ManagersFinance Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients. | Finance |
Algenis SpA
Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | Health Technology |
Levita Magnetics International Corp.
Levita Magnetics International Corp. Medical SpecialtiesHealth Technology Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA. | Health Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Health Technology |
Aurus Capital SA Administradora General de Fondos (Venture Ca
Aurus Capital SA Administradora General de Fondos (Venture Ca Investment ManagersFinance Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile. | Finance |
- Stock Market
- Insiders
- Alexander Seelenberger Farba
